Loading stock data…
$67.61+3.81 (+5.96%)
Tempus AI, Inc.
Tempus AI, Inc. in the Healthcare sector is trading at $67.61 with a market capitalization of $9.4B. Wall Street consensus targets $74.94 (18 analysts), implying a +10.8% move over the next 12 months. The stock is currently 28% below its 52-week high of $93.38, remaining 19.0% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Total Revenue | $314.63M↓ | $334.21M↓ | $367.21M↑ | $348.12M↓ | $382.49M |
| Gross Profit | $195.04M↓ | $209.94M↓ | $237.71M↑ | $222.04M↓ | $246.50M |
| Operating Income | -$61.77M↓ | -$61.00M↑ | -$61.41M↑ | -$84.71M↓ | -$75.91M |
| Net Income | -$42.84M↑ | -$79.98M↓ | -$54.17M↑ | -$125.92M↓ | $5.64M |
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytic...